Exploring the costs of a limited public actor antiretroviral treatment programme in South Africa

South African Medical Journal

Volumn 92, Issue 10, 2002, Pages 811-817

  Boulle, Andrew ^a   Kenyon, Christopher ^a   Skordis, Jolene ^a   Wood, Robin ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; DIDANOSINE; INDINAVIR; LAMIVUDINE; NEVIRAPINE; RITONAVIR; STAVUDINE; ZIDOVUDINE;

ARTICLE; CALCULATION; CONTROLLED STUDY; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DRUG COST; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH CARE UTILIZATION; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INVESTMENT; PUBLIC HEALTH SERVICE; SOUTH AFRICA;

ADULT; ANTI-HIV AGENTS; COST OF ILLNESS; COST SAVINGS; COST-BENEFIT ANALYSIS; DIRECT SERVICE COSTS; DRUG COSTS; DRUG MONITORING; HEALTH CARE COSTS; HEALTH CARE RATIONING; HEALTH SERVICES RESEARCH; HIV INFECTIONS; HUMANS; MODELS, ECONOMETRIC; NATIONAL HEALTH PROGRAMS; PROGRAM EVALUATION; PUBLIC HEALTH PRACTICE; PUBLIC SECTOR; SOUTH AFRICA; VALUE OF LIFE;

EID: 0036772874     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. World Health Organisation. Scaling Up Antiretroviral Therapy in Resource Limited Settings: Guidelines for a Public Health Approach. Geneva: WHO, 2002.
2. Egger M, May M, Chene G, et al. Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet 2002; 360: 119-129.
3. Hogg, RS, Yip B, Chan KJ, et al. Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy. JAMA 2001;286;2568-2577.
4. Berkman A. Confronting global AIDS: prevention and treatment. Am J Public Health 2001; 91: 1348-1349.
5. Farmer P, Leandre F, Mukherjee JS, et al. Community-based approaches to HIV treatment in resource-poor settings. Lancet 2001;358: 404-409.
6. Moatti JP, N'Doye I, Hammer SM, Hale P, Kazatchkine MD. Antiretroviral treatment for HIV-infected adults and children in developing countries: some evidence in favour of expanded diffusion. State of the Art: AIDS and Economics 2002; July, 96-116.
7. Kenyon C, Heywood M, Conway S. Mainstreaming HIV/AIDS: Progress and challenge. In: Ntuli A, ed. South African Health Review 2001: 161-183.
8. Bradshaw D, Johnson L, Schneider H, Bourne D, Dorrington R. Orphans of the HIV/AIDS Epidemic: The Time to Act is Now. Tygerberg: Medical Research Council, 2002.
9. Medicin Sans Frontieres. Affordable Antiretrovirals in South Africa: Protocol. Cape Town: MSF, 2001.
10. ASSA2000lite Aids and Demographic Model of the Actuarial Society of South Africa, http://www/assa.org.za (Downloaded on 13 Sept 2001).
11. Barlett JA, DeMasi R, Quinn J, Moxham C, Rousseau F. Overview of the effectiveness of triple combination therapy in antiretroviral-naive HIV-1 infected adults. AIDS 2001; 15: 1369-1377.
12. Reuter H, Kasper T, Poole, C, Skefile V, Goemaere E. Frequency, type, severity, and duration of adverse drug events on highly-active antiretroviral therapy (HAART) in a resource-poor setting. 14th International AIDS Conference, 2002.
13. Southern African HIV Clinicians Society. Clinical Guidelines: Antiretroviral Therapy in Adults. June 2002 version. Southern African Journal of HIV Medicine 2002; July, 22-29.
14. Improved methods and assumptions for estimation of the HIV/AIDS epidemic and its impact: Recommendations of the UNAIDS Reference Group on Estimates, Modelling and Projections. AIDS 2002; 16: W1-14.
15. Medicins Sans Frontieres. Providing Antiretroviral Therapy at Primary Care Clinics in Resource Poor Settings. Cape Town: MSF, 2002.
16. Orrell C, Bekker LG, Wood R. Adherence to antiretroviral therapy - achievable in the South African context? S Afr Med J 2001; 91: 483-484.
17. Abt Associates. HIV facts, figures and the future. In: Ntuli A, ed. South African Health Review, Durban: Health Systems Trust, 2000.
18. Karstaedt AS, Lee TCM, Kingdom AW, Schneider H. Care of HIV-infected adults at Baragwanath Hospital, Soweto: Part II. Management and cost of inpatients. S Afr Med J 1996; 86: 1490-1493.
19. Zwi K, Soderlund N, Schneider H. Cheaper antiretrovirals to treat AIDS in South Africa. They are at their most cost effective in preventing mother to child transmission. BMJ 2000; 320: 1551-1552.
20. Wood E, Braitstein P, Montaner JS, et al. Extent to which low-level use of antiretroviral treatment could curb the AIDS epidemic in sub-Saharan Africa. Lancet 2000; 355: 2095-2100.
21. Badri M, Wilson D, Wood R. Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study: Lancet 2002; 359: 2059-2064.